AGP Picks
View all

Falkland Islands Science Times
Provided by AGP

Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 2, 2026

SPARC AI Releases Latest Investor Presentation
Apr. 2, 2026

SPARC AI Releases Latest Investor Presentation

Indeterminate GlobeNewswire
Satellite Broadband Reaches an Inflection Point as Global Subscriptions Set to Exceed 43 Million by 2035
Apr. 2, 2026

Satellite Broadband Reaches an Inflection Point as Global Subscriptions Set to Exceed 43 Million by 2035

Indeterminate GlobeNewswire
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
Apr. 2, 2026

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium

Indeterminate GlobeNewswire
Roper Technologies schedules first quarter 2026 financial results conference call
Apr. 2, 2026

Roper Technologies schedules first quarter 2026 financial results conference call

Indeterminate GlobeNewswire
Wagner Acquires 9 Million Rezolve Ai Shares in Strong Vote of Confidence
Apr. 2, 2026

Wagner Acquires 9 Million Rezolve Ai Shares in Strong Vote of Confidence

Indeterminate GlobeNewswire
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
Apr. 2, 2026

Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026

Indeterminate GlobeNewswire
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Apr. 2, 2026

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Kustomer Launches “Kustomer AI - Signals” to Turn Customer Intelligence Into Real-Time Action Across the CX Stack
Apr. 2, 2026

Kustomer Launches “Kustomer AI - Signals” to Turn Customer Intelligence Into Real-Time Action Across the CX Stack

Indeterminate GlobeNewswire
VisionWave Converts Latin American Government Engagement into Initial Defense Order
Apr. 2, 2026

VisionWave Converts Latin American Government Engagement into Initial Defense Order

Indeterminate GlobeNewswire
Origin One’s Electronic Chain of Custody Form (eCCF) Platform Meets NLCP Requirements for Digital eCCF Systems
Apr. 2, 2026

Origin One’s Electronic Chain of Custody Form (eCCF) Platform Meets NLCP Requirements for Digital eCCF Systems

Indeterminate GlobeNewswire
authID Announces Strategic Partnership with Formula5 to Deliver Biometric Identity Security for Microsoft-First Enterprises
Apr. 2, 2026

authID Announces Strategic Partnership with Formula5 to Deliver Biometric Identity Security for Microsoft-First Enterprises

Indeterminate GlobeNewswire
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
Apr. 2, 2026

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Indeterminate GlobeNewswire
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer 
Apr. 2, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer 

Indeterminate GlobeNewswire
Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET
Apr. 2, 2026

Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET

Indeterminate GlobeNewswire
Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy
Apr. 2, 2026

Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy

Indeterminate GlobeNewswire
Red Cat Secures New Orders for Black Widow™ Drones from NATO Ally
Apr. 2, 2026

Red Cat Secures New Orders for Black Widow™ Drones from NATO Ally

Indeterminate GlobeNewswire
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
Apr. 2, 2026

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Indeterminate GlobeNewswire
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
Apr. 2, 2026

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
Apr. 2, 2026

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Falkland Islands Science Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.